Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-04-20 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
2024年度内部控制审计报告
Audit Report / Information Classification · 85% confidence The document is titled “内部控制审计报告” and is issued by a registered accounting firm (“立信会计师事务所”). It provides an audit opinion on the effectiveness of the company’s internal control over financial reporting as of December 31, 2024. It is not an Annual Report (10-K) or a simple publication announcement, but a standalone audit report on internal controls. Therefore, it matches the Audit Report / Information category. FY 2024
2025-04-20 Chinese
独立董事2024年度述职报告（罗春华）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2024 Annual Work Report" for Ningbo Xinzhi Biotechnology Co., Ltd. It details the independent director's attendance at board meetings, audit committee meetings, and shareholder meetings during 2024, as well as their duties and activities in supervising company governance and financial matters. The content is a detailed report of the independent director's work and responsibilities over the year, not an announcement or a brief summary. It does not contain financial statements or audit opinions themselves, but rather a narrative of the director's activities and oversight. This fits the category of Board/Management Information (MANG), which includes announcements of changes or reports related to the company's board or senior management activities. The document is not an Annual Report (10-K), Audit Report (AR), or Regulatory Filing (RNS) because it is focused on the independent director's duties and attendance rather than financial results or regulatory compliance filings. The document length is 3501 characters, which is sufficient for a detailed report but not a full financial report. Therefore, the best classification is MANG with high confidence.
2025-04-20 Chinese
立信会计师事务所（特殊普通合伙）关于宁波新芝生物科技股份有限公司2024年度募集资金年度存放与使用情况专项报告的鉴证报告
Audit Report / Information Classification · 89% confidence The document is a specialized attestation (“鉴证报告”) by an independent accounting firm on the company’s 2024 “募集资金存放与使用情况专项报告” (special report on deposit and use of raised funds). It is not an earnings release, a simple announcement, nor a full annual or interim report, but a standalone assurance/audit‐style report on a regulatory compliance document. This fits the “Audit Report / Information” category. FY 2024
2025-04-20 Japanese
2024年度审计报告
Audit Report / Information Classification · 91% confidence The document is a standalone audit report (审计报告) issued by a certified public accounting firm, complete with audit opinion, basis, key audit matters, and fully audited financial statements (balance sheet, income, cash flow, equity changes, notes) for the fiscal year 2024. It does not include narrative business review or management discussion typical of an Annual Report. This matches the definition of a standalone Audit Report / Information (AR). FY 2024
2025-04-20 Chinese
关于召开2024年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a notice announcing the convening of the 2024 Annual General Meeting (AGM) of Ningbo Scientz Biotechnology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed, and references to other filings such as the 2024 Annual Report and various board and supervisory reports. The document does not contain the actual annual report or financial statements but rather informs shareholders about the meeting and the matters to be voted on. The document length is 3827 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as AGM Information (AGM-R).
2025-04-20 Chinese
关于使用闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the use of idle funds to purchase financial products. It details the purpose, amount, decision-making process, risk analysis, and impact on the company. It includes references to board and supervisory committee meeting resolutions but does not contain financial statements or detailed financial performance data. The document is relatively short (1525 characters) and serves as a disclosure of a financing-related activity rather than a full financial report. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities involving the use of idle funds for investment in financial products.
2025-04-20 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.